Showing results (1891-1900 of 1,941) with videos related to

Sort By:
Pageof 195
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 15, 2013
Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomesLi-Ang Lee, Chung-Guei Huang, Kuo-Chien Tsao, et al.
Oral Oncology|November 12, 2021
Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastasesNai-Ming Cheng, Chung-Jan Kang, Chi-Ying Tsai, et al.
Blood|November 15, 2011
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implicationsHsin-An Hou, Yuan-Yeh Kuo, Chieh-Yu Liu, et al.
Trials|May 29, 2026
A culturally adapted online Mediterranean diet intervention for metabolic dysfunction-associated steatotic liver disease (TIMA): study protocol for a randomized controlled trialYing-Cheng Lin, Jia-Ru Wang, Te-Cheng Su, et al.
Cancers|January 11, 2022
Surgical Margins Status and Prognosis after Resection of Oral Cavity Squamous Cell Carcinoma: Results from a Taiwanese Nationwide Registry-Based StudyChung-Jan Kang, Yu-Wen Wen, Shu-Ru Lee, et al.
The EMBO Journal|October 15, 2017
RBPJ/CBF1 interacts with L3MBTL3/MBT1 to promote repression of Notch signaling via histone demethylase KDM1A/LSD1Tao Xu, Sung-Soo Park, Benedetto Daniele Giaimo, et al.
Oral Oncology|February 5, 2022
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort studyChung-Jan Kang, Yu-Wen Wen, Shu-Ru Lee, et al.
Cancer Medicine|September 24, 2021
cN+pN0 disease does not portend a less favorable prognosis compared with cN0pN0 in patients with resected oral cavity squamous cell carcinomaChien-Yu Lin, Li-Yu Lee, Nai-Ming Cheng, et al.
Clinical and Molecular Hepatology|August 4, 2025
Taiwan Liver Cancer Association Management Consensus Guidelines for Intermediate Stage Hepatocellular CarcinomaI-Cheng Lee, Hung-Wei Wang, Wei Teng, et al.
Blood|August 11, 2011
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogeneticsWen-Chien Chou, Sheng-Chieh Chou, Chieh-Yu Liu, et al.
Pageof 195